Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: Medicines Patent Pool
Price, profit and the Covid-19 health technology pool: The example of...
Christopher Garrison
-
May 28, 2020
The € 7.4 billion for Covid-19 product and vaccine development needs...
Ellen 't Hoen
-
May 5, 2020
Covid-19 intellectual property pool gaining support
Ellen 't Hoen
-
April 23, 2020
Urgent collective action to meet the challenge of this pandemic crisis:...
Christopher Garrison
-
March 30, 2020
Strong call for transparency on medicine prices, cost of R&D at...
Ellen 't Hoen
-
April 19, 2019
2018 Round-up of Noteworthy Medicines Law and Policy Events
Ellen 't Hoen
-
December 26, 2018
WIPO and pharma industry launch global medicines patent database
Ellen 't Hoen
-
September 27, 2018
Dolutegravir Patent Licences Can Provide Access To All
Ellen 't Hoen
-
July 26, 2017
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
This work is licensed under Creative Commons.